Integrin β3 haploinsufficiency modulates serotonin transport and antidepressant-sensitive behavior in mice

Neuropsychopharmacology

Volumn 40, Issue 8, 2015, Pages 2015-2024

  Mazalouskas, Matthew ^a   Jessen, Tammy ^a   Varney, Seth ^a   Sutcliffe, James S ^a,b   Veenstra Vanderweele, Jeremy ^c   Cook, Edwin H ^d   Carneiro, Ana M D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA3 INTEGRIN; CITALOPRAM; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; VITRONECTIN RECEPTOR; ENOLASE;

ADULT; ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; BRAIN SYNAPTOSOME; DRUG SENSITIVITY; FRACTIONATION; GENE; GENE INTERACTION; GENETIC VARIABILITY; HAPLOINSUFFICIENCY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; ITGB3 GENE; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAPHE NUCLEUS; SEROTONIN UPTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIL SUSPENSION TEST; ANALYSIS OF VARIANCE; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; INFANT; METABOLISM; NERVE CELL; SYNAPTIC MEMBRANE; TRANSGENIC MOUSE; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BIOLOGICAL TRANSPORT; GENE EXPRESSION REGULATION; HUMANS; INFANT; INTEGRIN BETA3; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHOPYRUVATE HYDRATASE; POLYMORPHISM, GENETIC; RAPHE NUCLEI; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC MEMBRANES;

EID: 84930820204     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.51     Document Type: Article

References (50)

1. Arai R, Karasawa N, Kurokawa K, Kanai H, Horiike K, Ito A (2002). Differential subcellular location of mitochondria in rat serotonergic neurons depends on the presence and the absence of monoamine oxidase type B. Neuroscience 114: 825-835.
2. Askenazy F, Candito M, Caci H, Myquel M, Chambon P, Darcourt G et al (1998). Whole blood serotonin content, tryptophan concentrations, and impulsivity in anorexia nervosa. Biol Psychiatry 43: 188-195.
3. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A et al (1998). Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44: 169-178.
4. Carneiro AM, Cook EH, Murphy DL, Blakely RD (2008). Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 118: 1544-1552.
5. Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, Veenstra-VanderWeele J (2011). Absence of preference for social novelty and increased grooming in integrin beta3 knockout mice: initial studies and future directions. Autism Res 4: 57-67.
6. Chan CS, Weeber EJ, Kurup S, Sweatt JD, Davis RL (2003). Integrin requirement for hippocampal synaptic plasticity and spatial memory. J Neurosci 23: 7107-7116.
7. Chan CS, Weeber EJ, Zong L, Fuchs E, Sweatt JD, Davis RL (2006). Beta 1-integrins are required for hippocampal AMPA receptordependent synaptic transmission, synaptic plasticity, and working memory. J Neurosci 26: 223-232.
8. Chang JC, Tomlinson ID, Warnement MR, Ustione A, Carneiro AM, Piston DW et al (2012). Single molecule analysis of serotonin transporter regulation using antagonist-conjugated quantum dots reveals restricted, p38 MAPK-dependent mobilization underlying uptake activation. J Neurosci 32: 8919-8929.
9. Charrier C, Machado P, Tweedie-Cullen RY, Rutishauser D, Mansuy IM, Triller A (2010). A crosstalk between beta1 and beta3 integrins controls glycine receptor and gephyrin trafficking at synapses. Nat Neurosci 13: 1388-1395.
10. Chavis P, Westbrook G (2001). Integrins mediate functional preand postsynaptic maturation at a hippocampal synapse. Nature 411: 317-321.
11. Cingolani LA, Thalhammer A, Yu LM, Catalano M, Ramos T, Colicos MA et al (2008). Activity-dependent regulation of synaptic AMPA receptor composition and abundance by beta3 integrins. Neuron 58: 749-762.
12. Cleare AJ (1997). Reduced whole blood serotonin in major depression. Depress Anxiety 5: 108-111.
13. Cook EH, Leventhal BL (1996). The serotonin system in autism. Curr Opin Pediatr 8: 348-354.
14. Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C et al (2007). Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 121: 243-256.
15. Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL et al (2008). Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 33: 353-360.
16. Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571-625.
17. DeLisi LE, Neckers LM, Weinberger DR, Wyatt RJ (1981). Increased whole blood serotonin concentrations in chronic schizophrenic patients. Arch Gen Psychiatry 38: 647-650.
18. Hale MW, Shekhar A, Lowry CA (2012). Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol 32: 695-708.
19. Hammock E, Veenstra-VanderWeele J, Yan Z, Kerr TM, Morris M, Anderson GM et al (2012). Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J Am Acad Child Adolesc Psychiatry 51: 712-721 e711.
20. Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM (2003). Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28: 148-152.
21. Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF et al (2006). Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J Biol Chem 281: 2012-2023.
22. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M et al (1999). Beta3-integrindeficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103: 229-238.
23. Katzman MA (2009). Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 23: 103-120.
24. Kennedy SH, Andersen HF, Thase ME (2009). Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin 25: 161-175.
25. Kramar EA, Bernard JA, Gall CM, Lynch G (2003). Integrins modulate fast excitatory transmission at hippocampal synapses. J Biol Chem 278: 10722-10730.
26. Ma N, Tan LW, Wang Q, Li ZX, Li LJ (2007). Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Psychiatry Res 150: 61-69.
27. Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I (2001). Antidepressant-like behavioral effects in 5-hydroxytryptamine( 1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 298: 1101-1107.
28. Milner R, Campbell IL (2002). The integrin family of cell adhesion molecules has multiple functions within the CNS. J Neurosci Res 69: 286-291.
29. Montgomery S, Hansen T, Kasper S (2011). Efficacy of escitalopram compared with citalopram: a meta-analysis. Int J Neuropsychopharmacol 14: 261-268.
30. Napolioni V, Lombardi F, Sacco R, Curatolo P, Manzi B, Alessandrelli R et al (2011). Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes. Eur J Hum Genet 19: 353-359.
31. Nikonenko I, Toni N, Moosmayer M, Shigeri Y, Muller D, Sargent Jones L (2003). Integrins are involved in synaptogenesis, cell spreading, and adhesion in the postnatal brain. Brain research. Dev Brain Res 140: 185-194.
32. Nishimura SL, Boylen KP, Einheber S, Milner TA, Ramos DM, Pytela R (1998). Synaptic and glial localization of the integrin alphavbeta8 in mouse and rat brain. Brain Res 791: 271-282.
33. Nurden AT, Fiore M, Nurden P, Pillois X (2011). Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood 118: 5996-6005.
34. Phillips GR, Huang JK, Wang Y, Tanaka H, Shapiro L, Zhang W et al (2001). The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron 32: 63-77.
35. Pozo K, Cingolani LA, Bassani S, Laurent F, Passafaro M, Goda Y (2012). beta3 integrin interacts directly with GluA2 AMPA receptor subunit and regulates AMPA receptor expression in hippocampal neurons. Proc Natl Acad Sci USA 109: 1323-1328.
36. Pozzi A, Zent R (2003). Integrins: sensors of extracellular matrix and modulators of cell function. Nephron Exp Nephrol 94: e77-e84.
37. Ramaiya A, Johnson JH, Karnes HT (1997). Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis. J Pharm Sci 86: 1497-1500.
38. Ruhe HG, Mason NS, Schene AH (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12: 331-359.
39. Verkes RJ, Hengeveld MW, van der Mast RC, Fekkes D, van Kempen GM (1998). Mood correlates with blood serotonin, but not with glucose measures in patients with recurrent suicidal behavior. Psychiatry Res 80: 239-248.
40. Wang R, Li ZQ, Han X, Li BL, Mi XY, Sun LM et al (2010). Integrin beta3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer. APMIS 118: 909-917.
41. Weiss LA, Kosova G, Delahanty RJ, Jiang L, Cook EH, Ober C et al (2006a). Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur J Hum Genet 14: 923-931.
42. Weiss LA, Ober C, Cook EH Jr (2006b). ITGB3 shows genetic and expression interaction with SLC6A4.Hum Genet 120: 93-100.
43. Weiss LA, Veenstra-Vanderweele J, Newman DL, Kim SJ, Dytch H, McPeek MS Jr et al (2004). Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet 12: 949-954.
44. Whyte A, Jessen T, Varney S, Carneiro AM (2014). Serotonin transporter and integrin beta 3 genes interact to modulate serotonin uptake in mouse brain. Neurochem Int 73: 122-126.
45. Wulsin LR, Musselman D, Otte C, Bruce E, Ali S, Whooley MA (2009). Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study. Psychosom Med 71: 260-265.
46. Yu L, Yuan X, Wang D, Barakat B, Williams ED, Hannigan GE (2014). Selective regulation of p38beta protein and signaling by integrin-linked kinase mediates bladder cancer cell migration. Oncogene 33: 690-701.
47. Zhu CB, Blakely RD, Hewlett WA (2006). The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31: 2121-2131.
48. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005). p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649-15658.
49. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD (2004). Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 65: 1462-1474.
50. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010). Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35: 2510-2520.